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The B cell antigen receptor (BCR) plays an essential
role in all phases of B cell development. Here we
show that the extracellular domains of murine and
human Igb form an I-set immunoglobulin-like struc-
ture with an interchain disulfide between cysteines
on their G strands. Structural and sequence analysis
suggests that Iga displays a similar fold as Igb. An
Igab heterodimer model was generated based on
the unique disulfide-bonded Igb dimer. Solution
binding studies showed that the extracellular
domains of Igab preferentially recognize the con-
stant region of BCRwith m chain specificity, suggest-
ing a role for Igab to enhance BCRm chain signaling.
Cluster mutations on Iga, Igb, and a membrane-
bound form of immunoglobulin (mIgM) based on
the structural model identified distinct areas of
potential contacts involving charged residues on
both subunits of the coreceptor and the Cm4 domain
of mIgM. These studies provide the first structural
model for understanding BCR function.
INTRODUCTION
The B cell antigen receptor (BCR) plays a critical role in all stages
of B cell development and function (Geisberger et al., 2006;
Reth, 1992). It consists of two principal components: an antigen
binding subunit and a signaling subunit. The antigen binding
subunit is a membrane-bound form of immunoglobulin (mIg)
with a short cytoplasmic tail lackingany signalingmotifs. Through
noncovalent interactions, mIg associates with a disulfide-linked
Igab (CD79a/CD79b) signaling heterodimer (Campbell et al.,
1991; Hermanson et al., 1988; Kashiwamura et al., 1990;
Venkitaramanet al., 1991), forming a complexwith 1:1 stoichiom-
etry (Schamel andReth, 2000; Tolar et al., 2005). Both Iga and Igb
contain a single immunoreceptor tyrosine-based activation motif
(ITAM) in their cytoplasmic domains (Cambier, 1995; Reth, 1989).
Upon antigen binding, the ITAMs of Iga and Igb are
phosphorylatedby theSrc-family kinase Lyn, initiating a signaling
cascade in B cells (Dal Porto et al., 2004; Gauld et al., 2002;934 Structure 18, 934–943, August 11, 2010 ª2010 Elsevier Ltd All riJumaa et al., 2005). Importantly, both positive and negative
selection of developing B lymphocytes as well as the survival
and activation of mature B cells depend critically on Iga and Igb
(Nemazee et al., 2000; Rajewsky, 1996). It was also established
that mIgM is absolutely dependent on the association with Igab
heterodimer for its cell-surface expression, whereas mIgG1 is
not (Venkitaraman et al., 1991).
A critical gap in our knowledge of how the BCRs transduce
signals is the molecular architecture of mIg-Igab complex. It is
well established that many multichain immune receptors, such
as T cell receptors (TCRs) and activating natural killer cell recep-
tors, associate with their signaling adaptor molecules through
interactions between positively and negatively charged amino
acid pairs in their transmembrane (TM) domains (Lanier, 2005).
For theBCR, only Igahas a charged residue in its transmembrane
domain, andmIgMand Igbcontain only twopolar residues in their
TM regions (Campbell et al., 1991; Reth, 1992). The presence of
a charged Glu residue in the TM portion of Iga led to the hypoth-
esis that interactions between mIgM and the Igab heterodimer
are primarily through Iga (Reth, 1992). However, recent studies
utilizing fluorescence resonance energy transfer (FRET) have
demonstrated that the cytoplasmic C terminus of Igb is posi-
tioned closer to mIg than Iga (Tolar et al., 2005; Wienands,
2005). Mutational studies confirmed a critical role for polar resi-
dues in the transmembrane region of mIgM and revealed that
YS to VV mutation in the TM region of m chain abolishes its
association with Igab heterodimer (Grupp et al., 1993). Later
experiments proposed that there is an ordered association of
BCR components during BCR assembly (Foy and Matsuuchi,
2001). An intriguing aspect of the BCR signaling subunit is its
structural and functional similarity to CD3 molecules in TCR
assembly. Unlike many signaling subunits in immune receptors
that do not have appreciable extracellular domains, Iga and Igb
have sizable extracellular domains, as do CD3d3 or CD3g3 heter-
odimers in TCRs (Call et al., 2002; Clevers et al., 1988; Kuhns
et al., 2006; Wegener et al., 1995). However, unlike Igab, CD3d3
and CD3g3 are not disulfide-bonded heterodimers.
The exact role of extracellular domains of Igab in BCR
assembly and signaling remains unresolved. It was reported
that the extracellular domain of Iga affects the expression level
of mIgM (Hombach et al., 1990). Moreover, Iga and Igb that
lack extracellular domains did not mediate transport of IgM to
the B cell surface (Alfarano et al., 1999; Indraccolo et al., 2002).
Recently, it was also reported that both extracellular andghts reserved
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Figure 1. Solution Binding of Immunoglobulins to Immobilized Igab
at 540 RU of Surface Densities
(A) The binding sensorgrams of recombinant Fcm at 10, 5, 2.5, 1.25, and
0.625 mM concentrations to immobilized Igab. The calculated dissociation
constant KD is 2.3 3 10
6 ± 1.1 3 106 mM.
(B) The binding responses of 3 mMFcm and various human immunoglobulins to
immobilized Igab. The responses were taken at the time point immediately
before the dissociation phase. The average and their standard deviations
are derived from three independent experiments.
Structure
Structure and Function of Igabtransmembrane regions of Igabmust be properly associated for
correct BCR assembly (Dylke et al., 2007). It is also interesting to
note that an excess of Igb has been observed in the endoplasmic
reticulum of B cells as a disulfide-bonded homodimer, although
its functional relevance is uncertain (Brouns et al., 1995; Schamel
et al., 2003). Based on amino acid sequences, the extracellular
domains of Iga and Igb are predicted to have a C2- and a V-set
immunoglobulin-like (Ig-like) fold, respectively (Hermanson
et al., 1988; Kashiwamura et al., 1990). In addition to the classical
Ig-fold intrachain disulfide bond, both Iga and Igb contain addi-
tional cysteines that form an interchain heterodimeric disulfide
bond. Igb also has an additional intramolecular disulfide bond.
At present, the cysteine assignment for the intra- and intermolec-
ular disulfide bonds in Igb remains controversial (Campbell et al.,
1991; Hermanson et al., 1988; Kashiwamura et al., 1990; Reth,
1992; Siegers et al., 2006). To further investigate the function of
Igab and its association with BCR, we determined crystal struc-
tures of the extracellular domains of murine and human Igb,
generatedastructuralmodel for Igab, carriedout solutionbinding
studiesbetween Igabandvarious isotypesof theBcell receptors,
and identified, throughmutational analysis, residueson theextra-
cellular portion of Igab as well as in the Cm4 domain of mIgM
involved in the receptor and coreceptor association. Together,
these studies provide the first structural model for our under-
standing of BCR architecture and activation.
RESULTS AND DISCUSSION
The Extracellular Domains of Iga and Igb Preferentially
Recognize BCR m Chain
In addition to mediating BCR signaling, Igab promotes the
surface expression of mIg heavy chains, in particular the m chain
ofBCR (Venkitaramanet al., 1991). In theabsenceof Igab,mchain
of BCR is retained in the endoplasmic reticulum (ER) through
interactions of its TM domain with calnexin (Grupp et al., 1995).
The association between Igab and mIg has been probed exten-
sively through mutations in the TM region of mIg and pinpointed
to a Tyr-Ser pair of amino acids (Blum et al., 1993; Grupp et al.,
1993; Pleiman et al., 1994; Venkitaraman et al., 1991; Williams
et al., 1994). The results showed that Igab interacts with mIg
primarily through its TM regions and that the extracellular
domains of Igab appear to be dispensable for BCR signaling.
However, the interactions between Igab andmIg in the TM region
alone are insufficient to explain the ER retention of m chain but not
g chain of mIg, as they share 70% similar TM sequences with the
Tyr-Ser pair conserved for all mIg isotypes.
To investigate the function of the extracellular region of Igab,
we examined the binding of soluble Igab to different Ig isotypes,
including IgM, IgG1, IgD, IgA, and IgE. Human Igab heterodimer
was expressed in insect cells as a leucine zipper fusion protein
(Igab-LZ). The constant portion of a human BCR m chain, corre-
sponding to Cm2–Cm4 domains (Fcm), was expressed in CHO
cells as adisulfide-bondeddimer and reactedwith ananti-human
IgM antibody. The solution binding experiments were carried out
using immobilized human Igab-LZ on CM5 sensor chips via
primary amine attachment. The analytes consisted of serial
dilutions of recombinant human Fcm and human IgM, IgA, IgD,
IgE, and IgG1. The solution binding showed that Igab bound
Fcm tightest, with a dissociation constant of 2 mM (Figure 1Structure 18, 93and Table 1). Interestingly, the intact IgMbound Igab significantly
less than Fcmdespite its being 103 larger than Fcm (Table 1), sug-
gesting that the presence of J chain on IgM interferes with Igab
binding. Similarly, IgA displayed weak binding to Igab at a high
level of coreceptor immobilization and failed to bind the corecep-
tor at low immobilization levels (Table 1). No binding was
observed between IgG1, IgD, IgE, and immobilized Igab under
any surface densities. Thus, the solution binding results showed
a preferential m chain association by the extracellular domains of
Igab, suggesting a unique role for the coreceptor in enhancing
BCRm signaling. This may contribute to lowering the signaling
threshold of the receptor and compensate for the lower m chain
antigen affinity during B cell development.
Structure Determination of Murine and Human Igb
To gain structural insights into the signaling chain of BCR, we
expressed the extracellular portions of human Iga (amino acids
33–143), Igb (amino acids 26–159), as well as their murine homo-
logs as recombinant proteins in Escherichia coli. The refolded4–943, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 935
Table 1. Solution Affinities of Fcm and Immunoglobulins Binding
to Igab
Igab
Immobilization (RU) 250 540 990 2096
Analyte (concentrations) Dissociation Constants, KD (mM)
Fcm (0–20 mM) 2.4 ± 2.9 2.3 ± 1.1 2.2 ± 2.2 0.9
IgM (0–20 mM) ND ND ND >10
IgA (0–20 mM) ND ND ND >10
IgG1 (0–6 mM) ND ND ND ND
IgE (0–6 mM) ND ND ND ND
IgD (0-6 mM) ND ND ND ND
ND, nondetectable binding.
Table 2. Data Collection and Refinement Statistics
Murine Igb
Monomer
Murine Igb
Homodimer
Human
Igb Homodimer
Data Collection
Space group P21212 P41212 P4132
Unit cell (A˚) a = 35.63,
b = 79.72,
c = 34.32
a = b = 87.97,
c = 75.29
a = 129.83
Resolution limit (A˚) 1.7 3.1 3.2
Unique reflections 10,471
(898)a
5,597
(541)
6,616
(630)
Redundancy 5.5 (2.3) 6.1 (5.4) 27.6 (28.7)
Completeness (%) 93.8 (67.4) 97.4 (98.7) 99.9 (100.0)
Rsym (%)
b 6.5 (31.7) 13.5 (50.6) 7.0 (33.9)
<I/s(I)> 21.5 (2.6) 14.1 (3.2) 55.6 (13.1)
Refinement
Resolution (A˚) 40–1.7 48–3.1 46–3.2
Number
of reflections
10,071 5,407 6,407
Number of
protein atoms
757 1,485 1,678
Number
of solvent atoms
92 26 2
Rcryst (%) 18.7 (27.0) 20.6 (27.8) 18.1 (20.7)
Rfree (%)
c 19.7 (29.0) 25.8 (32.0) 26.3 (36.2)
Mean B factor (A˚2) 31.7 52.1 77.2
Wilson B factor (A˚2) 20.6 59.7 75.8
Rmsd bond
lengths (A˚)
0.006 0.007 0.010
Rmsd bond angles () 1.18 1.39 1.39
a Values in parentheses are for highest resolution shells: 1.7–1.74 A˚,
3.21–3.10 A˚, and 3.31–3.20 A˚ for murine Igb monomer, murine Igb
homodimer, and human Igb homodimer, respectively.
bRsym = 100 3 SjIh  < Ih >j/SIh, where < Ih > is the mean intensity of
multiple measurements of symmetry-equivalent reflections.
c Rfree was calculated using a test set of 5%.
Structure
Structure and Function of Igabhuman Iga existed in mostly a monomeric form, whereas human
and murine Igb formed both monomers and dimers (see
Figure S1 available online). Both Iga and Igb, when immobilized
on aCM5 sensor chip, bound Fcm aswell as their respective anti-
bodies, suggesting that the refolded Iga and Igbwere functional.
We crystallized the monomeric and dimeric forms of murine Igb
as well as the dimeric form of human Igb. The crystals of the
monomeric Igb belonged to an orthorhombic space group
P21212 and contained one Igb monomer in each asymmetric
unit. The structure was determined by the molecular replace-
ment method despite less than 30% sequence identity between
Igb and the known structures of V-set Ig-like domains. The struc-
ture was refined to 1.7 A˚ resolution with crystallographic and free
R factors of Rcryst = 18.7% and Rfree = 19.7%, respectively
(Table 2). The refined electron density map was contiguous
from residue Cys43 to Leu142 except for the FG loop, between
residues 127 and 133, which appeared disordered (Figure S2).
The refined monomeric Igb structure was then used as the
search model in molecular replacement to solve both murine
and human dimeric Igb structures (Table 2). The structure of
the murine Igb dimer was refined to 3.1 A˚ resolution with a final
Rcryst and Rfree of 20.6% and 25.8%, respectively. The electron
densities are continuous between Cys43 and Leu142 for the
A subunit except for the FG loop (residues 125–129), and
between Ile46 and Phe144 for the B subunit except for part of
the C0D (residues 90–91) and FG (residues 124–132) loops. The
dimeric human Igb structure was refined to 3.2 A˚ resolution
with a final Rcryst and Rfree of 18.1% and 26.3%, respectively
(Table 2 and Figures 2 and 3). The refined (2Fo Fc) map showed
good electron density in both subunits throughout the whole
structure between Cys43 and Phe145.
The subunit structures of murine and human Igb are very
similar to one another, with a root-mean-square deviation
(rmsd) of 1.2 A˚ among 86 core Ca atoms (Figure 2C). The overall
structure of the Igb extracellular domain assumes an I-type Ig
fold with the two antiparallel b sheets formed by A-B-E-D and
A0-G-F-C strands and a characteristic disulfide bond between
Cys65 and Cys120 (Cys122 in human Igb) from the B and F
strands, respectively (Figure 2) (Harpaz and Chothia, 1994).
Like a V-type fold, a conserved proline residue, Pro50, breaks
the first b strand into two shorter strands, A and A0. However,
unlike the classical V-type domain, the I-type Igb does not
have a C00 b strand, leaving C0 strand to bridge the two b sheets
(Figure 2). As a consequence, the loop corresponding to the936 Structure 18, 934–943, August 11, 2010 ª2010 Elsevier Ltd All riputative second complementarity-determining region (CDR2) is
absent in Igb. The structural comparison between Igb and
several other members of the Ig superfamily such as the VH
and VL domains of an IgG1 (Protein Data Bank [PDB] ID code
1YQV), the Va and Vb domains of a TCR (1AO7), the Vg and Vd
domains of a gdTCR (1HXM), and CD8 (1CD8) resulted in rmsds
of 1.1–1.3 A˚ for 75–87 Ca atoms. In addition, Igb contains
a second intrachain disulfide bond formed between Cys43 and
Cys124 (Cys126 in human Igb), and an interchain disulfide
bond between Cys135 (Cys136 in human Igb) from both subunits
(Figure 3). Our structural data are in accordance with the
reported Igab heterodimer formation through Cys135 of murine
Igb in Drosophila S2 cells (Siegers et al., 2006).
Igb Forms a Distinct Dimer
Although its functional relevance is unclear, an excess of Igb
could be found in B cells as a disulfide-bonded homodimer
(Brouns et al., 1995; Schamel et al., 2003). The two subunits of
Igb are linked by a disulfide bond between Cys135 (Cys136 inghts reserved
Figure 2. The Structure of Murine and Human Igb
(A and B) Monomers frommurine (A) and human (B) Igb homo-
dimers are shown with their secondary-structure elements
labeled as in Figure 4. Cysteines (labeled in red) and disulfide
bonds are shown in stick representation. N and C termini are
marked.
(C) Structural comparison between murine Igb (cyan) and
human Igb (yellow) monomers. Positions of disulfide bonds
are shown with arrows. Labels are colored according to the
color of the corresponding molecule.
(D) Structural comparison between murine Igb (cyan) and VL
domain of IgG1 (red, PDB ID code 1YQV). Cysteines and
disulfide bonds are shown in stick representation, labeled
according to the Igb sequence. C0 and C00 strands, which are
different in the two structures, are labeled and colored
according to the color of the corresponding molecule. This
figure and all subsequent ribbon drawings are prepared using
the program PyMOL (http://www.pymol.org). See also
Figure S2.
Structure
Structure and Function of Igabhuman Igb) from the opposing G strands (Figure 3). Unlike many
covalent dimers, such as CD8, NKG2D, and NKG2A/CD94
receptors, that usually form disulfide bonds in their membrane
proximal stalk regions, the Igb intersubunit disulfide bond is
located in the middle of its Ig domain. Similar to the V domain
structures of antibodies and T cell receptors, the structure of
Igb contains a glycine residue, Gly136 (Gly137 in human Igb),
in the middle of the G strand, creating a b bulge that splits the
strand into G and G0 strands (Chothia, et al., 1998; Richardson,
1981). Interestingly, Cys135 (Cys136 in human Igb) is located
in the middle of the bulge, whose conformation makes the
cysteine readily accessible for the interchain disulfide-bond
formation (Figures 2 and 3). Although similar in overall dimer
formation, the relative orientations of two Igb subunits differ
between themurine and human homodimers as a result of a rota-
tion around the interchain disulfide bond (Figures 3A and 3C).
The murine dimer is asymmetrical and stabilized by interactions
between subunits A and B, including two salt bridges (Lys78
[A]–Glu138 [B] and Asp133 [A]–His49 [B]), one hydrogen bond
(Asn130 [A]–Tyr66 [B]), and hydrophobic interactions involvingStructure 18, 934–943, AugusIle117 (A), Phe119 (A), Gln45 (A), Lys78 (A), Trp47
(B), and Phe52 (B) (Figures 3A and 3B). In contrast,
the human Igb homodimer is symmetrical and
primarily formed through hydrogen bonds from
the side chains of Arg45 and Arg51 to the
main-chain atoms of the opposing subunit (Figures
3C and 3D). In addition to the current Igb-type
dimer, several types of immunoglobulin dimers
have been reported to date, including those in the
V domains of antibodies, TCRs, CD8, CTLA-4,
CD28, and TREM-1 (Cohen et al., 1996; Evans
et al., 2005; Garboczi et al., 1996; Harris et al.,
1992; Leahy et al., 1992; Ostrov et al., 2000;
Radaev et al., 2003; Schwartz et al., 2001)
(Figure S3). However, all these reported dimers
would position the interchain cysteines of Igb at
distances between 12 and 25 A˚, too far for disul-
fide-bond formation, and thus are incompatible
with the Igab structure.Based on initial sequence analysis, Iga was proposed to have
a C2-set Ig-like fold (Kashiwamura et al., 1990). The sequences
of Iga and Igb share less than 20% identity (Figure 4). However,
several structural features of Igb appear to also be present in the
structure of Iga. First, a conserved Pro35 in the first b strand of
Iga suggests its first strand is split into A and A0 strands, like
those in the V-type and I-type Ig fold. Second, the most
conserved region between Iga and Igb (60%of sequence iden-
tity) corresponds to the GG0 b bulge and the G0 strand of Igb
(Figure 4B). In particular, the four residues at the b bulge of Igb
(SCGT) are invariant in all Iga sequences (Figure 4C), suggesting
that the b bulge conformation of Igb is also present in the struc-
ture of Iga. This, together with the conserved Pro35 in Iga
sequences, likely creates A0 and G0 strand pairing in Iga that is
similar to that of Igb. The interchain disulfide-forming cystine,
Cys113 of Iga, is aligned against the dimer-forming cysteine
135 of murine Igb (Figure 4B), suggesting that the heterodimeric
disulfide bond is formed between Cys113 of Iga and Cys135 of
Igb (murine numbering). The sequence of Iga is also compatible
with the hydrogen bonding observed in the structure oft 11, 2010 ª2010 Elsevier Ltd All rights reserved 937
Figure 3. Murine and Human Igb Homodimer Formation
(A) Murine Igb homodimer with secondary-structure elements labeled. Monomers A and B are colored cyan and lemon, respectively.
(B) Detailed view of the hydrophobic core and hydrogen bonds (black dashed lines) at the homodimer interface with major side chains involved in the interactions.
(C) Human Igb homodimer. Monomers A and B are colored green and yellow, respectively.
(D) Detailed view of major side chains involved in the interactions at the human Igb interface. Cystine residues are shown in stick representation and labeled red.
See also Figure S3.
Structure
Structure and Function of Igabasymmetric murine Igb dimer (Figure S4). Because the dimeriza-
tion mode observed in Igb is the only one compatible with the
interchain disulfide bond through the GG0 b bulge cysteines,
we modeled the structure of Igab heterodimer based on that of
the asymmetric murine Igb dimer (Figure S4).
Identification of the Contact Regions between Igab
and the m Chain of BCR
The structure model of Igab reveals approximately nine polar
and charged patches on the surface of the heterodimer. To
further define the contact region between m chain of BCR and
Igab, we carried out cluster mutagenesis on both subunits of
Igab heterodimer as well as the m chain of BCR. Cluster muta-
tions, in which clusters of amino acids are replaced with
alanines, generally result in larger effects than single alanine
mutations and can be effectively used to map a ligand binding938 Structure 18, 934–943, August 11, 2010 ª2010 Elsevier Ltd All risite. However, a potential complication of cluster mutations is
their higher tendency to disrupt native conformations. Thus,
the approach requires conformational-sensitive validations,
such as antibody binding. Based on the human Igab model,
two surface-exposed Iga clusters, E48/D49/H51 (a2) and
R124/V125/R126 (a5), together with three individual amino
acid sites, H36 (a1), N60 (a3), and E85 (a4), were selected for
alanine mutations (Figure 5). Four Igb clusters, R55A/K56A/
R57A (b1), T60A/V61A/K62A (b2), K79A/Q80A/E81A (b3), and
Q123A/Q124A/K125A (b4), were also generated. The mutations
were carried out on Iga and Igb subunits to avoid mutations
affecting Igab heterodimer formation which would complicate
the mapping of the BCR binding site. Seven out of nine mutants
were successfully expressed in E. coli and refolded in vitro. Two
mutants, E48A/D49A/H51A (a2) of Iga and T60A/V61A/K62A
(b2) of Igb, failed to express. The refolded Iga and Igb mutantsghts reserved
Figure 4. Sequence Alignments of Igbs and Igas
(A) Sequence comparison of several mammalian and chicken Igbs. The numbering is consistent with the sequence of murine Igb. The secondary-structure
elements of Igb are illustrated as arrows for b strands. Cysteines are highlighted red. Residues involved in interactions at the interface of the murine Igb homo-
dimer are highlighted according to subunit color, that is, cyan and yellow for A andB subunits, respectively. Residues involved in the interactions at the interface of
human Igb are highlighted green.
(B) Sequence alignment of murine and human Igbs and Igas. The numbering is consistent with murine Igb (bold font) and Iga (regular font). Cysteines are high-
lighted red. Unique cystein 98 in murine Iga is highlighted magenta.
(C) Sequence alignment of several mammalian Igas in the area of predicted G and G0 strands. Conserved residues are highlighted gray. See also Figure S4.
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Structure and Function of Igabbound to their respective antibodies in solution under experi-
mental conditions. The mutational effects on BCR association
were analyzed by solution binding experiments on immobilized
Fcm sensor chips. The wild-type Iga and Igb exhibited similar
binding affinities to immobilized Fcm with dissociation constants
KD of 1 mM, suggesting their equal contribution to m chain
association (Figure S5). The binding of Iga and Igb mutants,
reconstituted at 4 mM concentration in PBS, to Fcm varied
significantly depending on the mutations. In particular, three
of the Iga mutants, H36A (a1), E85A (a4), and R124A/V125A/
R126A (a5), resulted in 5- to 10-fold reductions in their binding
to Fcm compared to the wild-type. One mutation, N60A (a3) of
Iga, exhibited a 2-fold increase in Fcm binding (Figure 5C).
Among the three mutants of human Igb, R55A/K56A/R57AStructure 18, 93(b1) and Q123A/Q124A/K125A (b4) each reduced their BCR
binding by 6-fold and 2-fold, respectively, whereas K79A/
Q80A/E81A (b3) increased binding moderately. First, the muta-
tions further support the conclusion that both subunits of Igab
are involved in BCR binding. Second, the mutations affecting
Fcm binding are broadly distributed rather than clustered on
the surface of Igab. Third, the loss of Fcm binding involves
both positively and negatively charged residues, such as argi-
nine and glutamate, suggesting significant electrostatic interac-
tions present at the BCR and Igab interface. In addition, the
location of these mutations and the size of Igab extracellular
domain suggest the membrane proximal Cm4 of BCR as the
most likely contact domain for the extracellular domains of
Igab heterodimer.4–943, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 939
Figure 5. Binding of Mutant Human Iga
and Igb to Recombinant Human Cm2–Cm4
(A) Surface representation of human Igab hetero-
dimer model. Point mutations resulting in reduc-
tion or increase of binding are circled red and
green, respectively. Mutations causing absence
of protein expression are circled black. a and
b chains of Igab heterodimer are colored pale
blue and yellow, respectively.
(B) 180 rotation of the previous view of the Igab
heterodimer model.
(C) Binding of Iga (gray bars) and Igb (white bars)
mutants to Cm2–Cm4. Mutant concentration in
the analyte was kept constant at 4 mM. At least
three sets of experiments were performed for
each mutant. A table with mutant description is
given for reference.
(D) Structural model of Cm3–Cm4 domains of IgM.
IgM chains are painted pink and gray with groups
of amino acids selected for mutation in red.
Groups of mutations m2 (R485, E486, S487) and
m8 (P562, H563) that affect IgM surface expression
are circled. Arginine 485 and proline 562 are highly
conserved in IgM.
(E) 90 rotation of the previous view.
(F) Relative surface expression of different IgM
groups of mutants (gray bars); white bars repre-
sent relative surface expression for IgM YS/VV
construct. The YS/VV mutation in transmembrane
domains of IgM allows surface IgM expression
without binding to the Igab heterodimer. This indi-
cates that the effects of the mutations were likely
through disrupting interactions with Igab. A table
with mutant descriptions is given for reference.
See also Figure S5.
Structure
Structure and Function of IgabTo investigate whether the Cm4 domain of mIgM is involved in
the binding to Igab, we used the mIgM surface expression on
J558L cells to measure Igab association, as mIgM expression
in this cell line is dependent on the assembly with Igab
(Reth, 1992). A structural model of Cm2–Cm4 domains of mIgM
wasgenerated from thecrystal structureof IgA toguide the selec-
tion of the mutational sites (Herr et al., 2003) (Figure 5). Based on
this model, nine groups of amino acids (clusters m1–m9) were
selected evenly across the surface of Cm4 for cluster mutational940 Structure 18, 934–943, August 11, 2010 ª2010 Elsevier Ltd All rights reservedanalysis to probe the Igab contact site.
Mutations were introduced into the B1-8
IgM heavy chain. Both the wild-type and
mutant mIgM were transfected into
J558L cells together with an Iga-YFP
plasmid, as J558L cells express endoge-
nous Igb (Tolar et al., 2005). Whereas
several cluster mutations mildly en-
hancedmIgM expression, twomutations,
R485/E486/S487 (m2) and P562/H563
(m8), reduced surface expression of
mIgM compared to that of the wild-type
as determined by surface staining with
anti-IgM antibodies (Figure 5F). Staining
of permeabilized cells indicated that all
mIgM constructs were present at similarlevels intracellularly, suggesting variations in mIgM surface
expression are not the result of transfection efficiency
(Figure S5). Combined mutations of R485/E486/S487 (m2) and
P562/H563 (m8) led to a further reduction in IgM surface expres-
sion without affecting intracellular levels of the IgM. The
constructs were expressed normally when we introduced a YS/
VV mutation into their transmembrane domains, which allows
surface IgM expression without binding to the Igab heterodimer
(Figure 5F), indicating that the effects of themutations were likely
Structure
Structure and Function of Igabthrough disrupting interactions with Igab. Interestingly, residues
in clusters m2 and m8 are conserved between human and mouse
IgM but variable among other immunoglobulins. Importantly,
residues affecting the association with Igab are spaced apart
on the Cm4 domain, which is in accordance with our mutational
studies on Iga and Igb. Moreover, the IgMmutants with reduced
binding to Igab also involve charged residues like Arg, His, and
Glu, which again points to the probable electrostatic nature of
interactions between BCR and Igab.
In summary, we determined the crystal structures of human
andmurine Igb. The structures adopt an IgI-like foldwith a unique
C0 strand positioned across the b sandwich bridging the C and D
strands. Both human and murine Igb form disulfide-bonded
dimers through cysteines from their G strands that are distinct
from the structures of existing Ig-like dimers. From the sequence
conservation and hydrogen-bonding patterns, we modeled the
Igab heterodimer structure based on the structure of the murine
Igb dimer. Solution binding experiments using soluble Igab
demonstrated a preferential recognition of m chain but not a, g,
d, and 3 chains of BCR, suggesting a role for Igab to enhance
BCR m chain signaling during B cell development and to
compensate low antigen affinity of m chain. To define the contact
region between m chain of BCR and extracellular domains of
Igab, a series of cluster mutations was generated on Iga and
Igb as well as m chain of BCR. The binding analysis based on
these cluster mutations showed an extensive contact surface
between Igab and BCR involving both subunits of Igab through
multiple charged residues.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The extracellular portions of human Iga (residues 33–143) and Igb (residues
26–159) and murine Igb (residues 27–159) were subcloned into a pET-30a
vector using NdeI and XhoI restriction sites. Human Iga and Igb mutants for
binding studies were generated using the standard protocol with a Quik-
Change kit (Stratagene). The recombinant proteins were expressed in E. coli
BL21 (DE3) cells as inclusion bodies and then reconstituted in vitro similarly
to previously described (Radaev et al., 2003). Human and mouse Igb showed
a high tendency in forming disulfide-bonded homodimers; however, during
murine Igb refolding, monomers with free cysteine blocked by glutathione
were also observed. The renaturated proteins were purified through an Ni-NTA
affinity column followed by a size-exclusion column (Superdex 200; GEHealth-
care). Purified proteins were dialyzed against the following buffers: murine Igb
against 10 mM Na acetate (pH 5.2); human Igb against water; and human Iga
against 50 mM NaCl, 5 mM Tris (pH 9.0). The identity of the refolded proteins
was confirmed by N-terminal amino acid sequencing, which showed some
N-terminal degradation for murine Igb.
The extracellular domains of human and murine Igab fused with a leucine
zipper (Igab-LZ) were expressed in insect cells using a similar procedure for
both proteins. In brief, the extracellular portion of Iga followed by a basic
leucine zipper and a six-histidine tag was inserted into pBACpl0p (Kozono
et al., 1994) between XhoI and MroI sites. The extracellular part of Igb followed
by an acidic leucine zipper and a FLAG tag was inserted into the same vector
between EcoRI and SphI sites. A thrombin site was engineered between Iga or
Igb and the leucine zippers. The vector was cotransfected with BaculoGold
linearized baculovirus DNA (Pharmingen) into sf9 cells. Recombinant virus
was amplified and proteins were expressed in High Five cells cultured in
Express Five SFM medium (Invitrogen) infected at a multiplicity of infection
of 6. Igab-LZ was purified using an Ni-NTA affinity column followed by
a size-exclusion Superdex 200 column. The Fc portion of a humanBCR m chain
(Fcm, amino acid residues 258–586), corresponding to Cm2–Cm4 regions, was
expressed as a disulfide-bonded dimer in CHO cells. Total RNA of a human BStructure 18, 93cell line, Daudi (American Type Culture Collection), was isolated using TRIZOL
reagent (Invitrogen). The cDNA synthesis of a human membrane-bound form
of IgM was performed utilizing a SuperScript First-Strand Synthesis System
for RT-PCR kit (Invitrogen). Human Fcm was PCR amplified from the cDNA
using primers 50-GGTTCTGCCTTTTCTCACCACCATCACCACCACCATCATA
TTGCTGAGCTGCCTCCC-30 and 50-CGGGATCCTCAGGTGGACTTGTCCAC
GGTCC-30. A second PCR was performed with primers 50-AAAGGGGCTAG
CGCCACCATGAAGTGGGTAACCTTTCTCCTCCTC-30 and 50-AGAAAAGGC
AGAACCGGAGATGAAGAGGAGGAGGAGAAAGGTTAC-30 to insert a rat
serum albumin leader sequence at the 50 end followed by a His8 tag sequence.
The segment was cloned into pIRES-neo3.0 plasmid (Clontech Laboratories),
which was then stably transfected into CHO-lec3.2.8.1 cells (kindly provided
by Dr. Pamela Stanley, Albert Einstein College of Medicine) using Lipofect-
amine 2000 (Invitrogen). G418-resisting clones were screened for Fcm expres-
sion by ELISA and the clone with the highest expression level was selected for
protein preparation. Conditioned CHO-S-SFM II spent medium containing
Igab-LZwas collected using anNi-NTA column and further purified on a Super-
dex 200 column.
Crystallization and Structure Determination
Single crystals of the monomeric form of murine Igb were obtained by vapor
diffusion in hanging drops at room temperature using reservoir solution con-
taining 20% PEG 750MME, 0.2 M MgCl2, and 0.1 M sodium citrate (pH 5.0).
Crystals of murine Igb homodimer grew in hanging drops with reservoir solu-
tion containing 0.72–1.0 M ammonium sulfate and 0.1 M Tris (pH 8.0–9.0),
whereas the crystals of human Igb homodimer were obtained in 0.6 M
Na formate and Na acetate (pH 4.0). The crystals of monomeric form of murine
Igb diffracted to 1.7 A˚, and contained one molecule per asymmetric unit. X-ray
data sets were collected at the Southeast Regional Collaborative Access
Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne
National Laboratory. Supporting institutions are listed at http://www.ser-cat.
org. The data were processed and scaled with HKL2000 (Otwinowski and
Minor, 1997). The structure was solved by molecular replacement using
CNS v1.1 (Brunger et al., 1998). The polyalanine-based search model
consisted of 70 core amino acids from the structure of TREM-1 (PDB ID
code 1Q8M) that encompass portions of the B, C, D, E, F, and G b strands
conserved among the V-type immunoglobulin structures. The program O
was used for model building and adjustments (Kleywegt and Jones, 1997).
Positional and individual B factor refinement was carried out using the
maximum-likelihood target function of CNS v1.1 (Brunger et al., 1998), fol-
lowed by REFMAC5 of the CCP4 program suite (CCP4, 1994; Murshudov
et al., 1997). A well-defined glutathione molecule forming a disulfide bond to
Cys124 was built into the electron density. The structure of the murine Igb ho-
modimer was determined to 3.1 A˚ resolution by molecular replacement using
the Igb monomer structure as a search model. The refinement and model
building were done using programs CNS v1.1 and O, respectively. Two well-
defined sulfate ions were located in the electron density map. The structure
of human Igb homodimer was determined to 3.2 A˚ resolution using murine
Igb monomer as the search model and refined using programs CNS v1.1
(Brunger et al., 1998), PHENIX.REFINE (Afonine et al., 2005), O (Kleywegt
and Jones, 1997), and Coot (Emsley and Cowtan, 2004).
Surface Plasmon Resonance
Human IgD (Calbiochem), human IgE, human IgA (Athens Research &
Technology), human IgM, human IgG1 k, and human IgG1 l (Sigma) were
purchased from commercial sources as indicated. Binding studies were
performed with a BIAcore 3000 instrument and analyzed with BIAevaluation
4.1 software (Biacore AB). Recombinant Igab leucine zipper fusion proteins
were immobilized individually onto a carboxymethylated dextran (CM5) chip
using primary amine coupling in 10 mM sodium acetate (pH 4.5–5.5) at
a flow rate of 10 ml/min to levels between 250 and 2000 response units (RU).
The binding experiments were performed using serial dilutions of analytes in
PBS buffer at a flow rate of 10 or 20 ml/min. Only the binding experiments
with Fcm as analyte displayed good binding kinetics. The following antibodies
were used as controls in binding studies: anti-human CD79a (clone JCB117;
Lab Vision), anti-human CD79b (clone CB3-1; BD Biosciences), and anti-
human IgM (Sigma). All recombinant proteins showed specific interactions
with their corresponding antibodies. Surfaces were regenerated by brief4–943, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 941
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Structure and Function of Igabinjection of either 10 mM NaOH or 10 mM glycine (pH 3.0). Dissociation
constants (KD) were determined from either kinetic or steady-state fittings
with BIAevaluation software. Binding studies on human Iga and Igb mutants
were performed in reverse orientation, where recombinant Fcm was immobi-
lized onto a CM5 chip using primary amine coupling in 10 mM sodium acetate
(pH 5.0). Anti-human CD79a (clone JCB117; Lab Vision) and anti-human
CD79b (clone CB3-1; BD Biosciences) antibodies were immobilized in sepa-
rate flow cells on the same sensor chip to monitor the conformational integrity
of mutant Iga and Igb. The analytes consisted of individual mutants dissolved
in PBS buffer at a constant concentration of 4 mM. Similar binding affinities
were obtained for the wild-type Iga and Igb in this reverse immobilization.
Surfaces were regenerated by brief injection of 5 mM NaOH and 5 mM glycine
(pH 2.0). At least three sets of experiments were performed for each mutant.
Cell-Surface Expression Analysis of IgM Mutants
The structure of Cm3–Cm4 domains of mouse IgM was modeled based on
the structure of IgA (Herr et al., 2003). The nine clusters of surface residues
of Cm4 identified for alanine mutations were: R479/E480/N483 (m1), R485/
E486/S487 (m2), R509/Q511 (m3), Q515/E516/K517 (m4), M524/P525/E526/
P527 (m5), P530 (m6), E543/E544/E545/N547/S548 (m7), P562/H563 (m8), and
E567/R568 (m9). Mutations were introduced into B1-8 IgM heavy chain in
pcDNA6 plasmid using a QuikChange kit (Stratagene). J558L cells were tran-
siently cotransfected with the IgM constructs and Iga-YFP using Amaxa elec-
troporation as described (Tolar et al., 2005). After 36 hr, cells were fixed in
paraformaldehyde, permeabilized or not with 0.1% Triton, and stained with
anti-IgM-Cy5 (Jackson ImmunoResearch) antibodies. Surface expression
was determined as mean fluorescence intensity of the IgM-positive cells
normalized on the signal from IgM wild-type transfected cells.
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